title: Telomerase, cell immortality, and cancer.
authors.affiliation: Geron Corporation, Menlo Park, California 94025, USA.
authors.forename: C B
authors.initials: CB
authors.lastname: Harley
authors.forename: N W
authors.initials: NW
authors.lastname: Kim
authors.forename: K R
authors.initials: KR
authors.lastname: Prowse
authors.forename: S L
authors.initials: SL
authors.lastname: Weinrich
authors.forename: K S
authors.initials: KS
authors.lastname: Hirsch
authors.forename: M D
authors.initials: MD
authors.lastname: West
authors.forename: S
authors.initials: S
authors.lastname: Bacchetti
authors.forename: H W
authors.initials: HW
authors.lastname: Hirte
authors.forename: C M
authors.initials: CM
authors.lastname: Counter
authors.forename: C W
authors.initials: CW
authors.lastname: Greider
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use; D002471:Cell Transformation, Neoplastic; D016922:Cellular Senescence; D004261:DNA Replication; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008954:Models, Biological; D009369:Neoplasms / Q000188:drug therapy / Q000201:enzymology / Q000209:etiology*; D010641:Phenotype; D019098:Telomerase / Q000037:antagonists & inhibitors / Q000378:metabolism*
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D019098:Telomerase